Cargando…
Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition
Targeting the early steps of the glycolysis pathway in cancers is a well-established therapeutic strategy; however, the doses required to elicit a therapeutic effect on the cancer can be toxic to the patient. Consequently, numerous preclinical and clinical studies have combined glycolytic blockade w...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343731/ https://www.ncbi.nlm.nih.gov/pubmed/30183475 http://dx.doi.org/10.1080/15384047.2018.1507666 |